Hey, this is Stocks_Pedia.
I'd like to introduce some unfamiliar companies that may be helpful to your investment.
The company I am going to introduce is $Marinus Pharmaceuticals(MRNS)$
It went public on July 31th, 2014 .
【Company Profile】
Marinus Pharmaceuticals, Inc., a pharmaceutical company, focuses on development and commercialization of products for patients suffering from rare genetic epilepsies and other seizure disorders.
It offers ZTALMY, an oral suspension for the treatment of seizures associated with cyclin-dependent kinase-like 5 deficiency disorder for adult. The company was incorporated in 2003 and is headquartered in Radnor, Pennsylvania.
【History & Events】
In 2014: Stifel Healthcare Conference
In 2016: Future Leaders in the Biotech Industry Conference
In 2017: American Academy of Neurology Medical Conference
In 2018: Jefferies 2018 Global Healthcare Conference
In 2019: Update on ganaxolone for treatment of RSE KOL Meeting at AES
In 2020: Oppenheimer Virtual Fireside Chat: Hot Topics in Epilepsy with KOL and Marinus Pharmaceuticals (MRNS) Management
In 2021: Marinus Pharmaceuticals Virtual Investor Event at American Epilepsy Society 2021 Annual Meeting
In 2022: 16th EILAT Conference on New Antiepileptic Drugs and Devices
【Main bussness segments】
【Net Income & Total Revenue】
【Competitors】
Intarcia Therapeutics
CureVac $CureVac B.V.(CVAC)$
Alembic Pharmaceuticals
EMS Pharma
Comments